StocksMedium•6 November 2026•
1 min read
Coloplast Shares Sink 4% as UBS Downgrades Stock Following Guidance Cut
Key Facts
1Coloplast shares fell 4% as UBS highlighted limited upside potential for the stock.
2The decline follows a recent cut in the company's financial guidance.
Coloplast shares fell 4% after UBS analysts issued a cautious note regarding the company's growth prospects. Investing.com reported that the decline was driven by the bank highlighting limited upside potential for the share price moving forward.
The downgrade follows Coloplast's recent decision to cut its forward-looking financial guidance, impacting investor sentiment within the healthcare sector. In related market activity, UBS shares closed at $48.77 on November 5, 2026, having traded between a low of $48.21 and a high of $50.71 during that session.